Real-World Evidence Deemed Essential For Breakthrough Designations

 
• By Brian Bossetta

A panel of experts in the health care and medical device industries discussed the fate of the Medicare Coverage for Innovative Technology (MCIT) rule during AdvaMed’s annual Medtech Conference.

RWE DATA FLASHDRIVE.
• Source: Alamy

More from Regulation

More from Policy & Regulation